Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 45 Information Technology 40 Financials 26 Industrials 23 Consumer Discretionary 6 Communication Services 5 Consumer Staples 4 Utilities 4 Materials 3 Energy 2 Real Estate 1

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 16 Healthcare Equipment & Supplies 11 Healthcare Providers & Services 9 Pharmaceuticals 7 Life Sciences Tools & Services 2
Curated industry list

Rapid Revenue Growth in Biotechnology on NASDAQ

Explore Rapid Revenue Growth in Biotechnology on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Alnylam Pharmaceuticals Inc (ALNY)
Fair Value9.9% Upside Fair Analyst64.4% Upside Market Cap29.304 B P/E39.5x Yield0.0% HealthGood
  NASDAQ Featured in Rapid Revenue Growth
Compugen Ltd (CGEN)
Fair Value15.4% Upside Fair Analyst101.3% Upside Market Cap225.4 M P/E6.2x Yield0.0% HealthExcellent
  NASDAQ Featured in Rapid Revenue Growth
Halozyme Therapeutics Inc (HALO)
Fair Value13.0% Upside Fair Analyst3.9% Upside Market Cap9.872 B P/E28.4x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Insmed Inc (INSM)
Fair Value-10.5% Downside Fair Analyst97.9% Upside Market Cap21.404 B P/E-18.1x Yield0.0% HealthFair
  NASDAQ Featured in Rapid Revenue Growth
MannKind Corp (MNKD)
Fair Value5.8% Upside Fair Analyst95.5% Upside Market Cap1.265 B P/E-55.3x Yield0.0% HealthGood
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks Small-Cap Stocks
Neurocrine Biosciences Inc (NBIX)
Fair Value27.7% Upside Undervalued Analyst32.0% Upside Market Cap16.88 B P/E23.3x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Rigel Pharmaceuticals Inc (RIGL)
Fair Value6.9% Upside Fair Analyst36.3% Upside Market Cap716 M P/E2.3x Yield0.0% HealthExcellent
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
Vericel Corp Ord (VCEL)
Fair Value16.0% Upside Fair Analyst33.7% Upside Market Cap2.373 B P/E95.8x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Aurinia Pharmaceuticals Inc (AUPH)
Fair Value-44.4% Downside Overvalued Analyst11.9% Upside Market Cap1.92 B P/E6.6x Yield0.0% HealthExcellent
  NASDAQ Featured in Overvalued Stocks Rapid Revenue Growth High-Growth Small-Cap Stocks Small-Cap Stocks
Genmab AS (GMAB)
Fair Value25.8% Upside Undervalued Analyst29.7% Upside Market Cap17.947 B P/E21.9x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
TG Therapeutics Inc (TGTX)
Fair Value24.1% Upside Undervalued Analyst53.7% Upside Market Cap6.907 B P/E16.0x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Travere Therapeutics Inc (TVTX)
Fair Value-4.0% Downside Fair Analyst8.9% Upside Market Cap5.281 B P/E-78.0x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Argenx NV ADR (ARGX)
Fair Value7.3% Upside Fair Analyst25.1% Upside Market Cap54.079 B P/E31.5x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth
Kiniksa Pharmaceuticals Ltd (KNSA)
Fair Value-4.3% Downside Fair Analyst25.5% Upside Market Cap5.929 B P/E75.5x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Momentum Stocks
Nanobiotix (NBTX)
Fair Value-31.8% Downside Overvalued Analyst13.6% Upside Market Cap1.991 B P/E-71.9x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Rapid Revenue Growth
Telix Pharmaceuticals Ltd ADR (TLX)
Fair Value-3.3% Downside Fair Analyst102.3% Upside Market Cap3.53 B P/E-495.4x Yield0.0% HealthGood
  NASDAQ Featured in Rapid Revenue Growth
Explore listed stocks on NASDAQ with company information and fair value data.